Skip to content

Metabolic Effects of Morning 16/8 Fasting

Short-term Metabolic Effects of Morning Energy Restriction Versus Two Different Early-day Nutrition Strategies

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04293003
Enrollment
10
Registered
2020-03-03
Start date
2020-01-07
Completion date
2020-02-29
Last updated
2020-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight and Obesity

Brief summary

A study to address the effects of early-day fasting on fat tissue mobilization in comparison to a typical isocaloric Mediterranean and a low-carbohydrate breakfast.

Detailed description

The study design meets a cross-over pattern with 3 different morning visits of 6 hour duration each. After an informed consent is received from the participant, a crude medical history, physical examination and collection of somatometric data through bio-impendance analysis will take place. An intravenous catheter will be placed in the participants forearm. At zero time point, depending on study visit, participants will either (A) remain fasted (B) start consuming ta pre-prepared zero-carbohydrate 500 kcal test meal (C) start consuming ta pre-prepared 500 kcal test meal with a composition conforming to a standard Mediterannean breakfast. Participants will be given 10 minutes to consume the meal. Blood samples will be drawn and visual analogue scales (VAS) for hunger and satiety will be filled in at the following time points (min): -15, 0, 15, 30, 60, 90, 120, 180, 240, 300, 360.

Interventions

OTHERfasting

6-hour fasting

Consumption of a zero-carbohydrate breakfast

OTHERMediterranean

Consumption of a Mediterranean-type breakfast

Sponsors

National and Kapodistrian University of Athens
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* BMI 18-25 kg/m2 * Willfulness to participate

Exclusion criteria

* Overweight or obesity (BMI\>25 kg/m2) * Type 1 or 2 diabetes mellitus * Uncontrolled thyroid disorders

Design outcomes

Primary

MeasureTime frameDescription
Mobilisation of adipose tissue6 hoursArea Under the Curve (AUC) of free fatty acid (FFA) and beta-Hydroxybutyrate (bOB) concentration

Secondary

MeasureTime frameDescription
Mobilisation of gut peptides6 hoursAUC of Ghrelin, Peptide YY and glucagon-like peptide -1 (GLP-1) concentration
Degree of appetite suppression6 hoursVisual Analogue Scale score (0-10, 0 equals minimal and 10 equals highest) for appetite
Degree of satiety induction6 hoursVisual Analogue Scale score (0-10, 0 equals minimal and 10 equals highest) for satiety

Countries

Greece

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026